Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine and Cisplatin in Advanced Penile Squamous Cell Carcinoma
NCT00210041Phase 2Completed
- Sponsor
- Institut Claudius Regaud
- Start
- Feb 2004
- Primary completion
- Dec 2011
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of gemcitabine and Cisplatin micelle injection (HA132) in penile squamous cell carcinoma (PSCC), sponsored by Institut Claudius Regaud. Primary endpoint: Objective Response Rate. Started Feb 2004; status: completed.
02
Drugs
gemcitabineCisplatin micelle injection (HA132)
03
Conditions
penile squamous cell carcinoma (PSCC)
Beyond the preview
Go deeper on NCT00210041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00210041.